Biomarkers of Inflammatory Bowel Disease

被引：63
|
作者：
Yi Fengming [1 ]
Wu Jianbing [1 ]
机构：
[1] Nanchang Univ, Affiliated Hosp 2, Dept Oncol, Nanchang 330006, Jiangxi, Peoples R China
来源：
DISEASE MARKERS | 2014年 / 2014卷
关键词：
SACCHAROMYCES-CEREVISIAE ANTIBODIES; ACTIVE ULCERATIVE-COLITIS; FECAL PYRUVATE-KINASE; MEAN PLATELET VOLUME; C-REACTIVE PROTEIN; CROHNS-DISEASE; INTESTINAL INFLAMMATION; NONINVASIVE MARKER; DIAGNOSTIC-VALUE; INDETERMINATE COLITIS;
D O I：
10.1155/2014/710915
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Inflammatory bowel disease (IBD) is a chronic disease mostly involved with intestine with unknown etiology. Diagnosis, evaluation of severity, and prognosis are still present as challenges for physicians. An ideal biomarker with the characters such as simple, easy to perform, noninvasive or microinvasive, cheap, rapid, and reproducible is helpful for patients and clinicians. Currently biomarkers applied in clinic include CRP, ESR, pANCA, ASCA, and fecal calprotectin. However, they are far from ideal. Lots of studies are focused on seeking for ideal biomarker for IBD. Herein, the paper reviewed recent researches on biomarkers of IBD to get advances of biomarkers in inflammatory bowel disease.
引用
收藏
页数：11
相关论文
共 50 条
  • [31] Common MicroRNA Biomarkers To Characterize Inflammatory Bowel Disease
    Lin, J.
    Zhao, Z.
    Welker, N. C.
    Liu, Y.
    Zhang, X.
    Zhang, J.
    Li, Y.
    Lee, H-J
    Bronner, M. P.
    MODERN PATHOLOGY, 2013, 26 : 443A - 443A
  • [32] Common MicroRNA Biomarkers To Characterize Inflammatory Bowel Disease
    Lin, J.
    Zhao, Z.
    Welker, N. C.
    Liu, Y.
    Zhang, X.
    Zhang, J.
    Li, Y.
    Lee, H-J
    Bronner, M. P.
    LABORATORY INVESTIGATION, 2013, 93 : 443A - 443A
  • [33] Longitudinal Study of Circulating miRNA Biomarkers in Inflammatory Bowel Disease
    Viennois, Emilie
    Zhao, Yuan
    Zhang, Mingzhen
    Han, Moon
    Merlin, Didier
    INFLAMMATORY BOWEL DISEASES, 2016, 22 : S6 - S6
  • [34] Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease
    Anet A Soubières
    Andrew Poullis
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2016, (01) : 41 - 50
  • [35] NONINVASIVE BIOMARKERS FOR INFLAMMATORY BOWEL DISEASE MONITORING: DRAWBACKS AND POTENTIAL
    Perry, Courtney
    Barrett, Terrence
    Yadav, Abhijeet
    Patel, Vihang
    Hashim, Mahmoud A.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 : S16 - S16
  • [36] Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response
    Elhag, Duaa Ahmed
    Kumar, Manoj
    Saadaoui, Marwa
    Akobeng, Anthony K.
    Al-Mudahka, Fatma
    Elawad, Mamoun
    Al Khodor, Souhaila
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [37] Biomarkers in Inflammatory Bowel Disease: What Surgeons Need to Know
    Dubinsky, Marla C.
    SEMINARS IN COLON AND RECTAL SURGERY, 2012, 23 (02) : 70 - 74
  • [38] Longitudinal study of circulating protein biomarkers in inflammatory bowel disease
    Viennois, Emilie
    Baker, Mark T.
    Xiao, Bo
    Wang, Lixin
    Laroui, Harried
    Merlin, Didier
    JOURNAL OF PROTEOMICS, 2015, 112 : 166 - 179
  • [39] Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults
    Krzystek-Korpacka, Malgorzata
    Kempinski, Radoslaw
    Bromke, Mariusz
    Neubauer, Katarzyna
    DIAGNOSTICS, 2020, 10 (06)
  • [40] Circulating Protein Signatures As Biomarkers for Inflammatory Bowel Disease Management
    Viennois, Emilie
    Baker, Mark
    Xiao, Bo
    Ayyadurai, Saravanan
    Laroui, Hamed
    Merlin, Didier
    GASTROENTEROLOGY, 2014, 146 (05) : S422 - S422
12345